Viewing Study NCT04861259


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-01-01 @ 9:19 AM
Study NCT ID: NCT04861259
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-24
First Post: 2021-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module